. 2014 Apr 15;3(2):85–92. doi: 10.1530/EC-14-0028
This work is licensed under a Table 1.
Clinical characteristics of the study population (n=15; 12 males and three females).
| Clinical characteristics | Mean (s.d.) | Range |
|---|---|---|
| Age (years) | 52.8 (13.9) | 24.1–69.7 |
| BMI (kg/m2) | 30.1 (6.2) | 21.4–41.1 |
| Systolic BP (mmHg) | 136 (20) | 109–179 |
| Diastolic BP (mmHg) | 84 (15) | 57–117 |
| Fasting insulin (pmol/l) | 142 (105) | 28–146 |
| Fasting glucose (mmol/l) | 5.5 (0.5) | 4.7–6.3 |
| GH (μg/l) | 7.2 (10.0) | 0.3–29.9 |
| Total IGF1 (nmol/l) | 79.7 (82.6) | 28.0–140.0 |
| IGFBP1 (μg/l) | 1.27 (1.28) | 0.00–4.20 |
| IGFBP3 (mg/l) | 7.0 (1.5) | 4.6–8.7 |
| IGF1 bioactivity (pmol/l) | 589 (237) | 218–1063 |
| S-Klotho (ng/l) | 2291 (2164) | 488–6823 |
| Ring size (mm) | 22.0 (2.5) | 17.5–24.5 |
| Comorbidity (n) | ||
| Secondary hypothyroidism | 3 | |
| Secondary hypogonadism | 3 | |
| Secondary adrenal failure | 1 | |
| Type 2 diabetes | 3 | |
| Hypertension | 6 |
BP, blood pressure.